|
Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical research trials and Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria). Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) clinical trial. Subjects frequently obtain the most expert healthcare possible for their Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria) Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
For Condition: Neutropenia,Fever,Neoplasms,Gram-Positive Bacterial Infections
Status: Completed
Sponsor(s): Pfizer ,
Synopsis: This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria)
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 13 Years/
Genders: Both
Protocol Entry Criteria: Other specific inclusion/exclusion criteria may apply. In order to determine eligibility, further examination by the investigator is necessary. Inclusion Criteria: - Patients must have neutropenia (ANC less than 500) with fever (oral temp 38.3 C). - Patients must have a cancer with recent chemotherapy and risks factors for gram positive infections. Exclusion Criteria: - Patients with fever due to known causes. - Patients with HIV. - Patients with recent bone marrow transplant. - Patients with an infected indwelling catheter that cannot be removed. - Patients who have received more than one day of another antibiotic before entering the trial. - Patients with endocarditis, osteomyelitis, meningitis, CNS infections.
Total Enrollment:
Location and Contact Information:
Research Center
Tacoma, Washington, 98405
United States
Research Center
Richmond, Virginia, 23249
United States
Research Center
Lexington, Kentucky, 40536
United States
Research Center
Los Angeles, California, 90033
United States
Research Center
Bronx, New York, 10467-2490
United States
Research Center
Kalamazoo, Michigan, 49001
United States
Research Center
Maywood, Illinois, 60153
United States
Research Center
Houston, Texas, 77030-4211
United States
Research Center
Youngstown, Ohio, 44501
United States
Research Center
Springfield, Illinois, 62701
United States
Research Center
Richmond, Virginia, 23294
United States
Research Center
Houston, Texas, 77030
United States
Research Center
Falls Church, Virginia, 22042
United States
Research Center
Worcester, Massachusetts, 01655
United States
Research Center
Orange, California, 92868
United States
Research Center
Jackson, Tennessee, 38301
United States
Research Center
San Diego, California, 92134
United States
Research Center
Perth Amboy, New Jersey, 08861
United States
Research Center
Hato Rey, , 00985
Puerto Rico
Research Center
Milwaukee, Wisconsin, 53226
United States
Research Center
Miami, Florida, 33136
United States
Additional Information:
Study ID Numbers: M/1260/0079;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00035425
Other Fever Studies:
1. Pegfilgrastim in Treating Neutropenia After Chemotherapy in Patients With Mantle Cell or Diffuse Large B-Cell Non-Hodgkin's Lymphoma
2. Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplastic Syndrome
3. Screening for Hematology Branch Protocols
4. Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
5. Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children with Fever and Neutropenia
Related Studies:
Other Fever Clinical Trials
Other Washington Clinical Trials
Other Tacoma Clinical Trials
Treatment of neutropenic patients with fever who are suspected to have a gram positive infection (a specific kind of bacteria)
|
|
|
|
|
|
|
|